Patents by Inventor John P. Kastelein

John P. Kastelein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LPL variant therapeutics
    Patent number: 9290751
    Abstract: The invention provides for the use of a therapeutic derived from a truncated lipoprotein lipase protein (LPL S447X), including nucleic acids encoding such proteins, for the treatment of conditions including LPL responsive conditions, such as cardiovascular disease, hypertension, LPL deficiency, high triglyceride levels, low HDL-cholesterol levels or atherosclerosis.
    Type: Grant
    Filed: July 4, 2014
    Date of Patent: March 22, 2016
    Inventors: Michael R. Hayden, John P. Kastelein
  • LPL VARIANT THERAPEUTICS
    Publication number: 20150030581
    Abstract: The invention provides for the use of a therapeutic derived from a truncated lipoprotein lipase protein (LPL S447X), including nucleic acids encoding such proteins, for the treatment of conditions including LPL responsive conditions, such as cardiovascular disease, hypertension, LPL deficiency, high triglyceride levels, low HDL-cholesterol levels or atherosclerosis.
    Type: Application
    Filed: July 4, 2014
    Publication date: January 29, 2015
    Inventors: Michael R. HAYDEN, John P. Kastelein